Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor
The present invention relates to a liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor. A liquid formulation containing botulinum toxin and stabilizing agent according to the present invention be can be easily stored and distributed. It was proved a significant effect on the stabilization of botulinum toxin under suitable conditions according to the temperature and pH of the human body. Thus, it is expected that the pharmaceutical composition of the present invention will greatly contribute to the safe and convenient medical use of botulinum toxin.
1. A pharmaceutical formulation, containing: a neurotoxin, a stabilizer and a local anesthetic.
2. The pharmaceutical formulation of claim 1 , wherein the neurotoxin is any one or more selected from the group consisting of botulinum toxin, tetanus toxin, cholera toxin, and pertussis toxin.
3. The pharmaceutical formulation of claim 2 , wherein the botulinum toxin is botulinum toxin type A.
4. The pharmaceutical formulation of claim 2 , wherein the botulinum toxin is either a form containing no complexing protein or a complex form containing a complexing protein.
5. The pharmaceutical formulation of claim 1 , wherein the stabilizer is any one or more selected from arginine, glutamic acid, aspartic acid, gluconolactone, and tartaric acid.
6. The pharmaceutical formulation of claim 1 , wherein the local anesthetic is lidocaine.
7. The pharmaceutical formulation of claim 1 , further containing polysorbate.
8. The pharmaceutical formulation of claim 1 , which is liquid.
9. A method for preparing a pharmaceutical formulation, comprising the steps of:
(a) purifying a neurotoxin; and
(b) adding a stabilizer and a local anesthetic to the neurotoxin.
10. The method of claim 9 , wherein the neurotoxin is any one or more selected from the croup consisting of botulinum toxin, tetanus toxin, cholera toxin, and pertussis toxin.
11. The method of claim 9 , wherein the stabilizer is any one or more selected from arginine, glutamic acid, and aspartic acid, gluconolactone, and tartaric acid.
12. The method of claim 9 , further adding polysorbate to the neurotoxin, stabilizer, and a local anesthetic.
13. The method of claim 9 , further comprising subsequent to steps (a) and (b), adding a liquid as step (c).